20 mg film-coated tablets
sildenafil
What Revatio is and what it is used for
Revatio contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 (PDE5) inhibitors.
Revatio lowers blood pressure in the lungs by dilating the blood vessels in the lungs.
Revatio is used to treat adults and children and adolescents from 1 to 17 years of age with high blood pressure in the blood vessels of the lungs ( pulmonary arterial hypertension ).
What you need to know before you take Revatio
Do not take Revatio
- if you are allergic to sildenafil or any of the other ingredients of this medicine (listed in section 6).
- if you are taking medicines that contain nitrates or nitric oxide donors such as amyl nitrite (“poppers”). These medications are often given to relieve angina (or angina pectoris ). Revatio can cause a severe increase in the effect of these medicines. Tell your doctor if you are taking any of these medicines. If you are not sure, ask your doctor or pharmacist.
- if you take riociguat. This medicine is used to treat pulmonary arterial hypertension (ie high blood pressure in the lungs) and chronic thromboembolic pulmonary hypertension (ie high blood pressure in the lungs due to blood clots). PDE5 inhibitors, such as Revatio, have been shown to increase the antihypertensive effect of this medicine. If you are taking riociguat or if you are not sure, talk to your doctor.
- if you have recently had a stroke, heart attack, severe liver disease, or very low blood pressure (<90/50 mmHg).
- if you are taking medicines containing ketoconazole or itraconazole to treat fungal infections or medicines containing ritonavir (for HIV ).
- if you have ever before lost your sight due to a problem with the blood flow to the nerve in the eye called non-arteritic anterior ischemic optic infarction/neuropathy (NAION).
Warnings and cautions
Talk to your doctor before taking Revatio if you:
- have a disease that is due to a blocked or narrowed vein in the lung, rather than a blocked or narrowed artery.
- have severe heart problems.
- have problems with the chambers of the heart.
- have high blood pressure in the blood vessels of the lungs.
- have low blood pressure at rest.
- loses a large number of body fluids ( dehydration ) which can occur if you sweat a lot or do not drink enough fluid. This can happen if you are sick with fever, vomiting, or diarrhea.
- have a rare inherited eye disease (retinitis pigmentosa).
- have abnormal red blood cells (sickle cell anemia), blood cell cancer ( leukemia ), bone marrow cancer (multiple myeloma ), and any disease of the penis or deformed penis.
- right now have stomach ulcers or a bleeding disorder (such as hemophilia ) or problems with nosebleeds.
- uses drugs for erectile dysfunction.
When used to treat male erectile dysfunction (ED), the following side effects on vision have been reported with PDE5 inhibitors, including sildenafil, at an unknown frequency: partial, sudden, temporary, or permanent visual impairment or loss of vision in one or both eyes.
If you experience sudden visual impairment or loss of vision, stop taking Revatio and contact your doctor immediately (see also section 4).
Prolonged and sometimes painful erections have been reported in men after using sildenafil. If you get an erection that lasts longer than 4 hours, stop taking Revatio and contact your doctor immediately (see also section 4).
Especially to take into account patients with kidney or liver problems:
You should tell your doctor if you have kidney or liver problems, as your dose may need to be adjusted.
Children
Revatio should not be given to children under 1 year of age.
Other medicines and Revatio
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines:
- Drugs containing nitrates, or nitric oxide donors such as amyl nitrite (“poppers”). These medicines are often given to relieve angina pectoris or angina (see section 2. What you need to know before taking Revatio).
- Tell your doctor or pharmacist if you are already taking riociguat.
- Treatment for pulmonary hypertension (eg bosentan, iloprost). Medicines containing St. John’s wort (herbal medicine), rifampicin (used to treat bacterial infections), carbamazepine, phenytoin, and phenobarbital (used, among others, to treat epilepsy ).
- Blood-thinning drugs (eg warfarin ) even if they do not show any side effects.
- Medicines containing erythromycin, clarithromycin, telithromycin ( antibiotics for the treatment of specific bacterial infections ), saquinavir (for the treatment of HIV ), or nefazodone (for depression), as your dose may need to be adjusted.
- Alpha-receptor blockers (eg doxazosin ) for the treatment of high blood pressure or prostate problems, as the combination of the two drugs, can cause symptoms that lead to a decrease in your blood pressure (eg dizziness and dizziness).
- Medicines containing sacubitril / valsartan used to treat heart failure.
Revatio with food and drink
You should not drink grapefruit juice while you are being treated with Revatio.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Revatio should be used during pregnancy only when needed.
Revatio should not be given to women of childbearing potential unless appropriate contraception is used.
Revatio passes into breast milk in very small amounts and is not expected to harm the baby.
Driving and using machines
Revatio can cause dizziness and affect vision. You should be aware of how you react to the medicine before driving or using machines.
Revatio contains sodium
Revatio 20 mg tablets contain less than 1 mmol (23 mg) sodium per tablet, ie essentially ‘sodium-free’.
How to take Revatio
Always take this medicine exactly as your doctor has told you. Ask your doctor or pharmacist if you are unsure.
For adults, the recommended dose is 20 mg three times daily (taken at 6 to 8-hour intervals) with or without food.
Use for children and adolescents
For children and adolescents between 1 year and 17 years of age, the recommended dose is either 10 mg three times daily for children and adolescents weighing 20 kg or less, or 20 mg three times daily for children and adolescents weighing more than 20 kg. Taken with or without food. Higher doses should not be used in children. This medicine should only be used when administering 20 mg 3 times daily. Other forms of medicine are more suitable for the treatment of patients weighing less than 20 kg, as well as for younger patients who can not swallow tablets.
If you use more Revatio than you should
Do not take more medicines than your doctor tells you to do. If you take more medicines than you have been told to take, contact your doctor immediately. Taking more Revatio than you should increase the risk of known side effects.
If you forget to take Revatio
If you forget to take Revatio, take a dose as soon as you remember. Then continue to take your medicine at the usual time. Do not take a double dose to make up for a forgotten dose.
If you stop taking Revatio
Sudden discontinuation of Revatio treatment may make your symptoms worse. Do not stop taking Revatio unless your doctor tells you to. Your doctor may ask you to reduce your dose for a few days before stopping completely.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Possible side effects
Like all medicines, Revatio can cause side effects, although not everybody gets them.
If you experience any of the following side effects, stop taking Revatio and contact your doctor immediately (see also section 2):
- if you experience a sudden deterioration or loss of vision (no known frequency).
- if you have an erection that lasts longer than 4 hours. Prolonged and sometimes painful erections have been reported in men after taking sildenafil (no known frequency).
Adults
The side effects that were reported as very common (may affect more than 1 in 10 people) were: headache, flushing, digestive problems, diarrhea, and pain in the arms and legs.
Side effects reported as common (may affect up to 1 in 10 people) were: subcutaneous infection, flu-like symptoms, sinusitis, decreased red blood cell count ( anemia ), fluid retention, difficulty sleeping, anxiety, migraines, tremors, numbness and tingling, burning sensation, decreased sensitivity of the skin, bleeding in the back of the eye, effects on vision, blurred vision and light shading, effect on color vision, eye irritation, bloodshot eyes / red eyes, dizziness, tracheal cataracts, nosebleeds, runny nose, cough, nasal congestion, stomach intestinal inflammation, heartburn, hemorrhoids, distended abdomen, dry mouth, hair loss, redness of the skin, night sweats, muscle aches, back pain, and increased body temperature.
Side effects that were reported as uncommon (may affect 1 in 100 people) were: decreased visual acuity, double vision, abnormal sensation in the eyes, bleeding in the penis, the presence of blood in semen and/or urine, and breast enlargement in men.
Skin rash and sudden loss or loss of hearing and decreased blood pressure have also been reported with an unknown frequency (frequency can not be calculated from the available data).
Children and young people
The following serious side effects have been reported commonly (occurring in up to 1 user in 10): pneumonia, heart failure, right ventricular failure, heart-related shock, high blood pressure in the lungs, chest pain, fainting, respiratory tract infection, tracheal inflammation, viral and intestinal viral infection.
The following serious side effects were considered treatment-related and have been reported as uncommon (occurring in up to 1 user in 100): allergic reactions (such as rash, swelling of the face, lips, and tongue, wheezing, difficulty breathing and swallowing), convulsions, irregular heartbeat, hearing loss, shortness of breath, inflammation of the stomach and intestines, wheezing due to obstructed airflow.
Side effects reported as very common (affects more than 1 user in 10) were: headache, vomiting, throat infection, fever, diarrhea, flu, and nosebleeds.
Side effects reported as common (affects up to 1 user in 10) include nausea, increased erection, pneumonia, and runny nose.
How to store Revatio
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiration date is the last day of the specified month.
Do not store above 30 ° C. Store in the original package. Moisture sensitive.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
Contents of the pack and other information
Content declaration
The active substance is sildenafil. Each tablet contains 20 mg of sildenafil (in the form of citrate).
- Other ingredients are Tablet core: microcrystalline cellulose, anhydrous calcium phosphate, croscarmellose sodium (see section 2 “Revatio contains sodium”), and magnesium stearate. Film coating: hypromellose, titanium dioxide (E171), lactose monohydrate (see section 2 “Revatio contains lactose”), glycerol triacetate.
What the medicine looks like and the contents of the pack
Revatio film-coated tablets are white and round. They are marked “PFIZER” on one side and “RVT 20” on the other side. The tablets are supplied in blister packs containing 90 tablets, 90 x 1 tablets in perforated unit dose blisters, and blister packs containing 300 tablets. Not all pack sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorisation Holder:
Upjohn EESV, 142 Rivium Westlaan, 2909 LD Capelle aan den IJssel, The Netherlands
Manufacturer:
Fareva Amboise, Industrial Zone, 29 Route des Industries, 37530 Pocé-sur-Cisse, France
Further information on this medicine can be obtained from the representative of the marketing authorization holder.
| Belgium / Belgique / BelgienPfizer SA / NVTel: +32 (0) 2 554 62 11 | LithuaniaPfizer Luxembourg SARL branches in LithuaniaTel. +3705 2514000 |
| BulgariaPfizer Luxembourg SARE, Clone of BulgariaTel: +359 2 970 433 | Luxembourg / LuxemburgPfizer SATel: +32 (0) 2 554 62 11 |
| Czech RepublicPfizer sroTel: + 420-283-004-111 | HungaryPfizer Kft.Tel .: + 36 1 488 37 00 |
| DenmarkViatris ApSTel: +45 28 11 69 32 | MaltaVivian Corporation Ltd.Tel: +356 21344610 |
| GermanyPfizer OFG Germany GmbHTel: +49 (0) 800 5500634 | The NetherlandsPfizer bvTel: +31 (0) 10 406 43 01 |
| EestiPfizer Luxembourg SARL Eesti subsidiaryTel: +372 666 7500 | NorwayPfizer ASTel: +47 67 52 61 00 |
| GreeceUPJOHN HELLAS ΕΠΕ:Ηλ: +30 2100 100 002 | AustriaPfizer Corporation Austria Ges.mbHTel: +43 (0) 1 521 15-0 |
| SpainViatris Pharmaceuticals, SLTel: +34 900 102 712 | PolandPfizer Polska Sp. z ooTel .: +48 22 335 61 00 |
| FranceViatris HealthTel: +33 (0) 4 37 25 75 00 | PortugalPfizer Laboratories, Lda.Tel: +351 21 423 5500 |
| CroatiaMylan Hrvatska dooTel: +385 1 23 50 599 | RomaniaPfizer România SRLTel: +40 21 207 28 00 |
| IrelandPfizer Healthcare IrelandTel: 1800 633 363 (toll free)+44 (0) 1304 616161 | SloveniaPfizer Luxembourg SARLPfizer, a company in the field of pharmaceuticals, LjubljanaTel: + 386 (0) 1 52 11 400 |
| IcelandIcepharma hf.Phone: + 354 540 8000 | Slovak RepublicPfizer Luxembourg SARL, organizerTel: + 421-2-3355 5500 |
| ItalyViatris Pharma SrlTel: +39 02 612 46921 | Finland / FinlandViatris OyPuh / Tel: +358 20 720 9555 |
| .ΠροςGPA Pharmaceuticals Ltd:Ηλ: +357 22863100 | SwedenViatris ABTel: + 46 (0) 8 630 19 00 |
| LatviaPfizer Luxembourg SARL subsidiary LatvijāTel: +371 670 35 775 | United Kingdom (Northern Ireland)Pfizer LimitedTel: +44 (0) 1304 616161 |